Skip to main navigation Skip to search Skip to main content

Experiences from 5-year therapeutic drug monitoring of the human immunodeficiency virus drugs lopinavir, nelfinavir, saquinavir, fosamprenavir, efavirenz, nevirapine, lamivudine, abacavir and zidovudine

  • Josef Donnerer (First author)

Research output: Contribution to journalConference abstract

Original languageEnglish
JournalBasic and Clinical Pharmacology and Toxicology
Publication statusPublished - 2007
Event9th Annual Congress of the German Association of Clinical Pharmacology - Kiel, Germany
Duration: 1 Nov 20073 Nov 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this